Iron oxide nanoparticles for use as an MRI contrast agent: Pharmacokinetics and metabolism
- 1 January 1991
- journal article
- Published by Elsevier BV in Magnetic Resonance Imaging
- Vol. 9 (3), 275-283
- https://doi.org/10.1016/0730-725x(91)90412-f
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Magnetic Starch Microspheres, Efficacy and Elimination A New Organ-Specific Contrast Agent for Magnetic Resonance ImagingInvestigative Radiology, 1990
- Theory and practice of site-specific drug deliveryAdvanced Drug Delivery Reviews, 1987
- Ferromagnetic contrast agents: A new approachMagnetic Resonance in Medicine, 1986
- Rapid, high-yield purification of cell surface membrane using colloidal magnetite coated with polyvinylamine: Sedimentation versus magnetic isolationBiochimica et Biophysica Acta (BBA) - Biomembranes, 1985
- Magnetic guidance of ferro-colloid-entrapped emulsion for site-specific drug delivery.CHEMICAL & PHARMACEUTICAL BULLETIN, 1983
- New magnetic drug carrierJournal of Pharmacy and Pharmacology, 1983
- Immunospecific ferromagnetic iron-dextran reagents for the labeling and magnetic separation of cellsJournal of Immunological Methods, 1982
- Magnetic Microspheres Prepared by Redox Polymerization Used in a Cell Separation Based on GangliosidesScience, 1978
- An electron microscopic study of the fenestrated endothelial lining of rat liver sinusoidsJournal of Ultrastructure Research, 1970
- Comparaison des actions hépatocancérogènes de la diéthylnitrosamine et du p-diméthylaminoazobenzèneInternational Journal of Cancer, 1967